These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25861218)

  • 1. Selective Mycobacterium tuberculosis Shikimate Kinase Inhibitors as Potential Antibacterials.
    Gordon S; Simithy J; Goodwin DC; Calderón AI
    Perspect Medicin Chem; 2015; 7():9-20. PubMed ID: 25861218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.
    Freitas de Freitas T; Roth CD; Abbadi BL; Hopf FSM; Perelló MA; de Matos Czeczot A; de Souza EV; Borsoi AF; Machado P; Bizarro CV; Basso LA; Timmers LFSM
    J Comput Aided Mol Des; 2023 Mar; 37(3):117-128. PubMed ID: 36547753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
    Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI
    Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikimate kinase: a potential target for development of novel antitubercular agents.
    Pereira JH; Vasconcelos IB; Oliveira JS; Caceres RA; de Azevedo WF; Basso LA; Santos DS
    Curr Drug Targets; 2007 Mar; 8(3):459-68. PubMed ID: 17348838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
    Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
    J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shikimate Kinase Inhibitors: An Update on Promising Strategy against
    Rajput VS; Runthala A; Khan IA
    Curr Drug Targets; 2023; 24(5):388-405. PubMed ID: 36752299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel antimicrobial compounds targeting Mycobacterium tuberculosis shikimate kinase using in silico hierarchical structure-based drug screening.
    Kawamoto S; Hori C; Taniguchi H; Okubo S; Aoki S
    Tuberculosis (Edinb); 2023 Jul; 141():102362. PubMed ID: 37311288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicological Profiling of Potential Shikimate Kinase Inhibitors Against
    Jhangiani A; Panda V; Sukheja A; Thomas S; Dusseja P; Pandya S; Chintakrindi A
    Altern Lab Anim; 2024 Jan; 52(1):10-27. PubMed ID: 38095084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of mechanism and chemical inhibitors of shikimate kinase.
    Chagaleti BK; Reddy MBR; Saravanan V; B S; D P; Senthil Kumar P; Kathiravan MK
    J Biomol Struct Dyn; 2023; 41(23):14582-14598. PubMed ID: 36974959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
    Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
    Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
    Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; Santos DS; de Azevedo WF
    Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of Mycobacterium tuberculosis shikimate kinase in complex with shikimic acid and an ATP analogue.
    Gan J; Gu Y; Li Y; Yan H; Ji X
    Biochemistry; 2006 Jul; 45(28):8539-45. PubMed ID: 16834327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of irreversible inhibition of Mycobacterium tuberculosis shikimate kinase by ilimaquinone.
    Simithy J; Fuanta NR; Hobrath JV; Kochanowska-Karamyan A; Hamann MT; Goodwin DC; Calderón AI
    Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):731-739. PubMed ID: 29654976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition.
    Simithy J; Gill G; Wang Y; Goodwin DC; Calderón AI
    Anal Chem; 2015 Feb; 87(4):2129-36. PubMed ID: 25629762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of shikimic acid with shikimate kinase.
    Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; de Azevedo WF; Santos DS
    Biochem Biophys Res Commun; 2004 Dec; 325(1):10-7. PubMed ID: 15522194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based Discovery of Narirutin as a Shikimate kinase Inhibitor with Anti-tubercular Potency.
    Sahu PK; Mohapatra PK; Rajani DP; Raval MK
    Curr Comput Aided Drug Des; 2020; 16(5):523-529. PubMed ID: 31654517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations.
    Vianna CP; de Azevedo WF
    J Mol Model; 2012 Feb; 18(2):755-64. PubMed ID: 21594693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.